Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease

Despite the massive investment in Alzheimer’s disease (AD), there are still no disease-modifying treatments (DMTs) for AD. One major reason is attributed to the limitation of clinical "one‐size‐fits‐all” approach, since the same AD treatment solely based on clinical diagnosis was unlikely to ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qihui, Su, Shijie, Cai, Chuipu, Xu, Lina, Fan, Xiude, Ke, Hanzhong, Dai, Zhao, Fang, Shuhuan, Zhuo, Yue, Wang, Qi, Pan, Huafeng, Gu, Yong, Fang, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015208/
https://www.ncbi.nlm.nih.gov/pubmed/36936813
http://dx.doi.org/10.1016/j.csbj.2023.02.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015208/
https://www.ncbi.nlm.nih.gov/pubmed/36936813
http://dx.doi.org/10.1016/j.csbj.2023.02.041

Ejemplares similares